206 related articles for article (PubMed ID: 27449910)
1. The Diagnostic Dilemma of Neurolymphomatosis.
Shree R; Goyal MK; Modi M; Gaspar BL; Radotra BD; Ahuja CK; Mittal BR; Prakash G
J Clin Neurol; 2016 Jul; 12(3):274-81. PubMed ID: 27449910
[TBL] [Abstract][Full Text] [Related]
2. Neurolymphomatosis: a single-center experience of neuromuscular manifestations, treatments, and outcomes.
Jeong J; Kim SW; Sung DH
J Neurol; 2021 Mar; 268(3):851-859. PubMed ID: 33098033
[TBL] [Abstract][Full Text] [Related]
3. Primary neurolymphomatosis presenting as foot drop: A rare case report.
Bakshi N; Chand V; Anand R; Duggal R
Indian J Pathol Microbiol; 2023 Jul; ():. PubMed ID: 38391312
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of FDG-PET in neurolymphomatosis: report of five cases.
Kinoshita H; Yamakado H; Kitano T; Kitamura A; Yamashita H; Miyamoto M; Hitomi T; Okada T; Nakamoto Y; Sawamoto N; Takaori-Kondo A; Takahashi R
J Neurol; 2016 Sep; 263(9):1719-26. PubMed ID: 27286845
[TBL] [Abstract][Full Text] [Related]
5. Neurolymphomatosis of the Sciatic and Tibial Nerves.
Yaseen MT; Aziz PAA; Siddique K; Tariq TA
J Coll Physicians Surg Pak; 2019 Dec; 29(12):S86-S88. PubMed ID: 31779751
[TBL] [Abstract][Full Text] [Related]
6. Neurolymphomatosis--diagnosis and assessment of treatment response by FDG PET-CT.
Lin M; Kilanowska J; Taper J; Chu J
Hematol Oncol; 2008 Mar; 26(1):43-5. PubMed ID: 17957824
[TBL] [Abstract][Full Text] [Related]
7. Neurolymphomatosis - Rare presentation in non-Hodgkin's lymphoma: The role of
Fatima N; Zaman MU; Zaman A; Zaman SU
World J Nucl Med; 2020; 19(2):159-161. PubMed ID: 32939208
[TBL] [Abstract][Full Text] [Related]
8. Neurolymphomatosis as primary presentation of extra-nodal NK/T-cell lymphoma, nasal type.
Silva MI; Santos P; Viegas D; Miranda M; Montes V; Pita F; Carmona C
Neurol Sci; 2024 Mar; ():. PubMed ID: 38472552
[TBL] [Abstract][Full Text] [Related]
9. Secondary neurolymphomatosis of spinal nerve roots detected by ¹⁸F-FDG PET/CT: a case report and differential diagnosis of the case.
Wang Y; Wang J; Jiang C; Peng Q; Wu M; Ma X
Hell J Nucl Med; 2015; 18(3):261-3. PubMed ID: 26574697
[TBL] [Abstract][Full Text] [Related]
10. Diffuse large B-cell lymphoma relapse presenting as extensive neurolymphomatosis.
Nepal P; Batchala PP; Rehm PK; Fadul CE
Neuroradiol J; 2020 Jun; 33(3):230-235. PubMed ID: 32401669
[TBL] [Abstract][Full Text] [Related]
11. Increasing importance of 18F-FDG PET in the diagnosis of neurolymphomatosis.
Salm LP; Van der Hiel B; Stokkel MP
Nucl Med Commun; 2012 Sep; 33(9):907-16. PubMed ID: 22714006
[TBL] [Abstract][Full Text] [Related]
12. 18F-FDG PET/CT/MRI Fusion Images Showing Cranial and Peripheral Nerve Involvement in Neurolymphomatosis.
Trevisan AC; Ribeiro FB; Itikawa EN; Alexandre LS; Pitella FA; Santos AC; Simões BP; Wichert-Ana L
Indian J Nucl Med; 2017; 32(1):77-78. PubMed ID: 28242998
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Yield of FDG-PET/CT, MRI, and CSF Cytology in Non-Biopsiable Neurolymphomatosis as a Heralding Sign of Recurrent Non-Hodgkin's Lymphoma.
Shaikh F; Chan AC; Awan O; Jerath N; Reddy C; Khan SA; Graham MM
Cureus; 2015 Sep; 7(9):e319. PubMed ID: 26487995
[TBL] [Abstract][Full Text] [Related]
14. Quantitative Imaging Analysis of FDG PET/CT Imaging for Detection of Central Neurolymphomatosis in a Case of Recurrent Diffuse B-Cell Lymphoma.
Shaikh F; Savells D; Awan O; Inayat F; Chaudhry A; Jerath N; Graham MM
Cureus; 2015 Nov; 7(11):e379. PubMed ID: 26719822
[TBL] [Abstract][Full Text] [Related]
15. High-grade B-cell lymphoma relapse presenting as neurolymphomatosis of the median nerve.
Tai R; Maingard J; Nambiar M; Lim K
BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30846458
[TBL] [Abstract][Full Text] [Related]
16. Primary Extranodal NK/T-Cell Lymphoma Presenting as Neurolymphomatosis Involving Multiple Cranial Nerves: A Case Report.
Ghosh S; Azzi J; Chan AM; Nael K; Renteria AS; Steinberg A; Petersen BE
Acta Haematol; 2022; 145(1):97-105. PubMed ID: 34569490
[TBL] [Abstract][Full Text] [Related]
17. Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab.
Gan HK; Azad A; Cher L; Mitchell PL
Neuro Oncol; 2010 Feb; 12(2):212-5. PubMed ID: 20150388
[TBL] [Abstract][Full Text] [Related]
18. Clinical manifestations of, diagnostic approach to, and treatment of neurolymphomatosis in the rituximab era.
Khurana A; Novo M; Nowakowski GS; Ristow KM; Spinner RJ; Hunt CH; King RL; Lachance DH; Habermann TM; Micallef IN; Johnston PB
Blood Adv; 2021 Mar; 5(5):1379-1387. PubMed ID: 33661298
[TBL] [Abstract][Full Text] [Related]
19. Neurolymphomatosis: MRI and (18) FDG-PET features.
Lim AT; Clucas D; Khoo C; Parameswaran BK; Lau E
J Med Imaging Radiat Oncol; 2016 Feb; 60(1):92-5. PubMed ID: 25974748
[TBL] [Abstract][Full Text] [Related]
20. [Neurolymphomatosis due to enteropathy-associated T-cell lymphoma clinically diagnosed by FDG-PET/CT and subsequently confirmed by autopsy].
Uematsu N; Sumi M; Kaiume H; Takeda W; Kirihara T; Ueki T; Hiroshima Y; Ueno M; Ichikawa N; Watanabe M; Kobayashi H
Rinsho Ketsueki; 2018; 59(1):69-74. PubMed ID: 29415941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
